COMMON EQUITY (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of stock-based compensation awards granted

During the nine months ended September 30, 2024, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:

Award Type	Number of Awards
Stock options (1)	294,990
Restricted shares (2)	108,484
Performance units	205,051

(1)Stock options awarded had a weighted-average exercise price of $84.92 and a weighted-average grant date fair value of $16.19 per option.

(2)Restricted shares awarded had a weighted-average grant date fair value of $84.97 per share.

Schedule of Common Stock Outstanding Roll Forward

We had the following changes to our outstanding common stock during the three and nine months ended September 30, 2024:

	Three Months Ended September 30, 2024	Nine Months Ended September 30, 2024
Common stock shares outstanding at beginning of period	316,079,401	315,434,531
Shares issued:
Stock-based compensation	137,936	300,602
401(k)	38,400	285,000
Stock investment plan	98,709	334,313
Common stock shares outstanding at end of period	316,354,446	316,354,446